Department of Obstetrics and Gynecology, Capital Medical University, Beijing, People's Republic of China.
Hum Reprod. 2013 Sep;28(9):2350-62. doi: 10.1093/humrep/det258. Epub 2013 Jun 28.
Can the chemokine CXCL6 affect trophoblast cell migration and invasion in human first-trimester placenta?
Chemokine CXCL6 inhibits trophoblast cell migration and invasion by suppressing matrix metalloproteinase (MMP)-2 activity in human first-trimester placenta.
Several chemokines including CXCL8, CXCL12, CXCL14, CXCL16, CX3CL1, CCL14 and CCL4 can promote or inhibit trophoblast cell migration and invasion in human first-trimester placenta.
STUDY DESIGN, SIZE, DURATION: We used the trophoblast cell line HTR8/SVneo cells, primary trophoblast cells and villi explants to investigate the effect of rhCXCL6 on trophoblast cell migration and invasion.
PARTICIPANTS/MATERIALS, SETTING, METHODS: First, the CXCL6 RNA transcript level was detected in HTR8/SVneo cells derived from human first-trimester, second-trimester and third-trimester placenta by RT-PCR. Protein expression of CXCL6 and its receptors was tested in first-trimester placenta by immunohistochemistry. Secreted CXCL6 protein was detected in HTR8/SVneo cell supernatants by enzyme-linked immunosorbent assay. Secondly, the effect of rhCXCL6 on HTR8/SVneo cell proliferation was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Thirdly, the effect of rhCXCL6 on cell migration and invasion of HTR8/SVneo cells, primary trophoblast cells and villi explants was tested by transwell migration and invasion assays, respectively. Last, MMP-2 and MMP-9 activity in the supernatants of HTR8/SVneo and primary trophoblast cells treated by rhCXCL6 in the invasion assay was assessed by gelatin zymography.
Abundance of the CXCL6 RNA transcript increased with pregnancy development. CXCL6 and its receptor were expressed in several cells at the human maternal-fetal interface. RhCXCL6 inhibited trophoblast cell migration and invasion by suppressing MMP-2 activity.
LIMITATIONS, REASONS FOR CAUTION: These experiments are only in vitro.
According to the literature, CXCL6 could promote tumour cell migration and invasion by accelerating MMP-9 activity. However, CXCL6 inhibited trophoblast cell migration and invasion by suppressing MMP-2 activity in human first-trimester interface. These data suggest that strict regulation of CXCL6 is required for normal migration and invasion of cells, such as those involved at the maternal-fetal interface.
趋化因子 CXCL6 是否会影响人早孕胎盘滋养层细胞的迁移和侵袭?
趋化因子 CXCL6 通过抑制基质金属蛋白酶(MMP)-2 活性抑制人早孕胎盘滋养层细胞的迁移和侵袭。
包括 CXCL8、CXCL12、CXCL14、CXCL16、CX3CL1、CCL14 和 CCL4 在内的多种趋化因子可促进或抑制人早孕胎盘滋养层细胞的迁移和侵袭。
研究设计、规模、持续时间:我们使用滋养层细胞系 HTR8/SVneo 细胞、原代滋养层细胞和绒毛外植体来研究 rhCXCL6 对滋养层细胞迁移和侵袭的影响。
参与者/材料、设置、方法:首先,通过 RT-PCR 检测源自人早孕、中孕和晚孕胎盘的 HTR8/SVneo 细胞中 CXCL6 的 RNA 转录本水平。通过免疫组织化学检测 CXCL6 及其受体在早孕胎盘中的蛋白表达。通过酶联免疫吸附试验检测 HTR8/SVneo 细胞上清液中分泌的 CXCL6 蛋白。其次,通过 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴盐测定法评估 rhCXCL6 对 HTR8/SVneo 细胞增殖的影响。第三,通过 Transwell 迁移和侵袭测定分别检测 rhCXCL6 对 HTR8/SVneo 细胞、原代滋养层细胞和绒毛外植体迁移和侵袭的影响。最后,通过明胶酶谱法评估 rhCXCL6 处理后 HTR8/SVneo 和原代滋养层细胞上清液中 MMP-2 和 MMP-9 活性。
CXCL6 的 RNA 转录本丰度随妊娠进展而增加。CXCL6 及其受体在人母胎界面的几种细胞中表达。rhCXCL6 通过抑制 MMP-2 活性抑制滋养层细胞的迁移和侵袭。
局限性、谨慎的原因:这些实验仅在体外进行。
根据文献,CXCL6 可通过加速 MMP-9 活性促进肿瘤细胞的迁移和侵袭。然而,CXCL6 通过抑制 MMP-2 活性抑制人早孕界面滋养层细胞的迁移和侵袭。这些数据表明,对 CXCL6 的严格调节对于细胞的正常迁移和侵袭是必要的,例如参与母胎界面的细胞。